Glucotrack, INC. (GCTK) — DEF 14A Filings

All DEF 14A filings from Glucotrack, INC.. Browse 5 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (5)

Glucotrack Seeks Shareholder Nod for 20%+ Stock Issuance to Sixth Borough — Oct 3, 2025 Risk: medium
Glucotrack, Inc. (GCTK) is seeking stockholder approval for the issuance of common stock to Sixth Borough Capital Fund, LP, which could represent over 20% of th
Glucotrack Files DEF 14A on Executive Compensation — Apr 28, 2025 Risk: low
Glucotrack, Inc. filed a DEF 14A on April 28, 2025, detailing executive compensation and stock awards for the fiscal year ending December 31, 2024. The filing i
Glucotrack, Inc. Files Definitive Proxy Statement — Dec 6, 2024 Risk: low
Glucotrack, Inc. filed a Definitive Proxy Statement (DEF 14A) on December 6, 2024. This filing is related to the company's proxy materials, which are typically
Glucotrack Files Definitive Proxy Statement — Aug 19, 2024 Risk: low
Glucotrack, Inc. filed a Definitive Proxy Statement (DEF 14A) on August 19, 2024. This filing is related to the company's proxy materials, which are typically u
GlucoTrack, Inc. Announces 2023 Annual Meeting of Stockholders on April 26, 2024 — Apr 1, 2024 Risk: medium
GlucoTrack, Inc. (GCTK) filed a Proxy Statement (DEF 14A) with the SEC on April 1, 2024. The 2023 Annual Meeting of Stockholders for GlucoTrack, Inc. will be he

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX